Active comparator stratified randomization study effect oral bepotastine besilate as new treatment for allergic rhinitis.

Trial Profile

Active comparator stratified randomization study effect oral bepotastine besilate as new treatment for allergic rhinitis.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Sep 2013

At a glance

  • Drugs Bepotastine (Primary) ; Leukotriene receptor antagonists
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Sep 2013 Status changed from not stated to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 12 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top